CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Survey to assess Post traumatic stress and anxiety at inclusion and 6 months laterWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D040921 Stress Disorders, Traumatic NIH 0.22
D013313 Stress Disorders, Post-Traumatic NIH 0.20

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 COVID-19 EPIDEMIC Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder

The COVID-19 pandemic is a traumatic event which could lead to a greater risk of developing post-traumatic stress disorder, especially in cancer patients who feel more at risk of contracting the virus, and fear developing serious symptoms. The study's primary objective is to measure the presence of a potential post-traumatic stress disorder in cancer patients, and to assess the associated factors. The secondary objectives are to measure patients' anxiety, as well as their perception of both the management of their cancer care, and their fear of a cancer recurrence. It is a prospective, multi-centric study using self-assessing survey offered to cancer patients currently under ongoing care or treatment. The surveys will be sent by post at the beginning of the study, and again 6 months later. Expecting a participation rate of 40%, 4000 patients will be contacted, over a period of 3 months, in order to receive 1600 responses, and 640 responses 6 months later. Researching the factors associated with the appearance of post-traumatic stress could lead to better screening of patient disorders in highly anxiety-provoking crisis situations. As a result, it would lead to an improvement of their care, healthcare organization, and their follow-up in the case of a new epidemic or any other stressful event of this magnitude. Furthermore, promoting the patient's expression capabilities favors their implication in their care, and facilitates the development of health democracy.

NCT04401046 Cancer Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later
MeSH:Stress Disorders, Traumatic Stress Disorders, Post-Traumatic

Primary Outcomes

Measure: Score of the Impact of Event Scale Revisited scale

Time: at inclusion and 6 months later

Secondary Outcomes

Description: The factors associated with post traumatic stress, measured by the Impact of Event Scale Revisited scale

Measure: Factors associated with post-traumatic stress disorder

Time: at inclusion and 6 months later

Description: The measure of anxiety, measured by the State-Trait Anxiety Questionnaire

Measure: Measure of the patient's anxiety

Time: at inclusion and 6 months later

Measure: proportion of patients perceiving poorer management of their cancer care since the start of the COVID-19 epidemic.

Time: at inclusion and 6 months later

Measure: proportion of patients perceiving the implementation of all necessary measures to reduce the risk of exposure to COVID-19

Time: at inclusion and 6 months later

Measure: proportion of patients stating that remote consultation is as useful as a face-to-face consultation

Time: at inclusion and 6 months later

Measure: proportion of patients with access to a clinical psychology consultation (at the hospital or on the phone)

Time: at inclusion and 6 months later

Measure: Score on the cancer recurrence scale

Time: at inclusion and 6 months later


No related HPO nodes (Using clinical trials)